ReviewFrontiers in neurology2023

Digital endpoints in clinical trials of Alzheimer's disease and other neurodegenerative diseases: challenges and opportunities.

Anna-Katharine Brem et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.